Brief: Immutep Announces Initial Safety Data From First-In-Human Phase I Trial Evaluating IMP761
17/12/2024 14:06
Dec 17 (Reuters) - Immutep Ltd IMM.AX :
* IMMUTEP ANNOUNCES INITIAL SAFETY DATA FROM FIRST-IN-HUMAN
PHASE
I TRIAL EVALUATING IMP761
* IMMUTEP LTD - NO TREATMENT RELATED ADVERSE EVENTS IN FIRST
THREE
COHORTS
Source text: ID:nGNXKPrTB
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))